Zobrazeno 1 - 10
of 323
pro vyhledávání: '"J, Roeper"'
Autor:
J. Roeper, Keith L. Davis, Saurabh P Nagar, W. Sawyer, Nicolas Girard, Aliki Taylor, Ning Yu, Parisa Karimi, Frank Griesinger, Josephine Feliciano, Riyaz Shah
Publikováno v:
Drugs-Real World Outcomes
Background Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the preferred first-line (1L) therapy for EGFR mutation-positive (EGFRm) advanced/metastatic non-small cell lung cancer (NSCLC). Objective Our objective was to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7648870337f1d8ce7badf51ce41557e
http://europepmc.org/articles/PMC8605952
http://europepmc.org/articles/PMC8605952
Publikováno v:
Future Oncology. 17:471-486
Clinical trial and real-world data in non-small-cell lung cancer indicate that 10–60% of patients that progressed on first- or second-generation EGFR-targeting tyrosine kinase inhibitors (TKI) do not receive systemic second-line therapy. In our art
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::256b43b763da14b671265c8f24a50ca9
https://doi.org/10.2217/fon-2020-0854
https://doi.org/10.2217/fon-2020-0854
Publikováno v:
62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V..
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79819e10af95b51978ec525090edefe4
https://doi.org/10.1055/s-0042-1747762
https://doi.org/10.1055/s-0042-1747762
Autor:
Lukas C. Heukamp, Mark Kriegsmann, J. Roeper, Sonja Loges, L.M. Brückner, N. Magios, M. Faehling, Martin E. Eichhorn, Daniel Kazdal, Petros Christopoulos, A. Stenzinger, Katharina Kriegsmann, Martin Wermke, Martina Kirchner, Michael Meister, Marc A. Schneider, Frank Griesinger, Fjf Herth, Volker Endris, Thomas Muley, Roland Penzel, Tilmann Bochtler, Melanie Janning, Michael Thomas, Helge Bischoff, R. El Shafie, Farastuk Bozorgmehr, Felix C. Saalfeld, J.R. Fischer, C.P. Heussel, Peter Schirmacher, Anna-Lena Volckmar
Publikováno v:
Lung Cancer. 148:105-112
Objective Panel-based next-generation sequencing (NGS) is increasingly used for the diagnosis of EGFR-mutated non-small-cell lung cancer (NSCLC) and could improve risk assessment in combination with clinical parameters. Materials and methods To this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6efa6cba68effd65666675870981e77
https://doi.org/10.1016/j.lungcan.2020.08.007
https://doi.org/10.1016/j.lungcan.2020.08.007
Autor:
U Stropiep, Lukas C. Heukamp, Linda Diehl, Markus Falk, J. Roeper, Athena Chalaris-Rißmann, H. Ramdani, Katrin Wedeken, Frank Griesinger, Markus Tiemann, Anne Christina Lueers, Fabian Otto-Sobotka
Publikováno v:
Oncotarget
// Julia Roeper 1 , 3 , 6 , Markus Falk 2 , 6 , Athena Chalaris-Rismann 2 , 6 , Anne C. Lueers 1 , 3 , Hayat Ramdani 1 , 3 , 6 , Katrin Wedeken 4 , Ursula Stropiep 3 , 6 , Linda Diehl 7 , Markus Tiemann 2 , 6 , Lukas C. Heukamp 2 , 6 , Fabian Otto-So
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28c03e62378bec3fd22f8441c34ddada
http://europepmc.org/articles/PMC6980625
http://europepmc.org/articles/PMC6980625
Publikováno v:
Annals of Oncology. 33:S716-S717
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef38364968f57b11e82eeb636e818ff5
https://doi.org/10.1016/j.annonc.2022.07.531
https://doi.org/10.1016/j.annonc.2022.07.531
Publikováno v:
Journal of Thoracic Oncology. 17:S251-S252
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::014002bdd30c0d539b37f37f9465e35c
https://doi.org/10.1016/j.jtho.2022.07.426
https://doi.org/10.1016/j.jtho.2022.07.426
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chrisoph J. Szuszies, J. Roeper, Frank Griesinger, Michael Thomas, Melanie Janning, Hauke Winter, Niklas Beumer, Christoph Thomas Michaeli, Linna Sommer, Nikolaj Frost, Tobias Overbeck, Charles D. Imbusch, Sonja Loges, Tobias Boch, Martin Wermke
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 164
Objectives Immune checkpoint inhibitors (ICI) have significantly improved outcome of patients with advanced NSCLC and recently also showed benefit in early-stage disease. Patients with oligometastatic disease (OMD) harbor limited metastases, resectab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b456a3ad08644e27cfad5a0da591645
https://pubmed.ncbi.nlm.nih.gov/34998106
https://pubmed.ncbi.nlm.nih.gov/34998106
Publikováno v:
Annals of Oncology. 33:S1077
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d75fc785e116ce46e088689db1fb54e
https://doi.org/10.1016/j.annonc.2022.07.1279
https://doi.org/10.1016/j.annonc.2022.07.1279